Indian Pharma Has Little Reason to Fear Trump

The Next Wave of Rising Costs Facing Workers

As businesses confront elevated interest rates, global tariff pressures, and heavy capital investments in artificial intelligence, rising medical benefit costs represent an emerging headwind that employers will inevitably pass along to workers through higher payroll deductions, larger deductibles, and suppressed wage growth.

Indian Pharma Has Little Reason to Fear Trump

Indian pharmaceutical firms have spent decades supplying American patients with affordable medicines. That dominance will be difficult to challenge, despite President Donald Trump’s threat to impose steep tariffs on imported generic drugs.

Fed Faces High-Stakes Test at Jackson Hole

Host of Bloomberg Money Tom Keene and Veda Partners Co-Founder Henrietta Treyz are on Bloomberg this weekend and discuss how investors will be watching for how Warsh addresses inflation, market volatility and Fed independence as economic and geopolitical uncertainty complicate the outlook.

AI Risks Grow as Consumers and Bond Markets Raise Concerns

AI risks, consumer weakness, bond market warnings, and tariffs are shaping the outlook for investors and the broader economy.

Michigan Democrats Prepare for Major Shake-Up in Key Senate Race

Michigan’s Senate primary highlights the growing divide within the Democratic Party, with the outcome potentially shaping the balance of power in Congress.